Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideEWEdwards Lifesciences
FinDog View：Neutral
| Metric | ABBV | EW |
|---|
| Close | 262.51 | 89.28 |
| Market Cap | $464B | $51.5B |
| 1M | +4.87% | −1.68% |
| P/E (TTM) | 73.7 | 51.2 |
| Forward P/E | 16.8 | 29.8 |
| P/E 5-Yr Percentile | 51 | 98 |
| P/S | 7.2 | 7.9 |
| P/B | — | 4.9 |
| Dividend Yield | 4.47% | — |
| Latest Quarter Revenue | $17.0B | $1.7B |
| Revenue YoY | +10.2% | +13.6% |
| Gross Margin | 74.7% | 77.5% |
| Latest Quarter EPS | 2.03 | 0.42 |
| Avg Post-Earnings Move | ±1.7% | ±3.9% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.91% | 2.34% |
| 90-Day Net Insider Buying | −$8.2M | −$4.6M |
ABBV · Revenue, Last 8 Quarters ($B)
EW · Revenue, Last 8 Quarters ($B)
